These effects, along with a preceding report exhibiting that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like conduct in mice,2 aid the principle of targeting ACKR3 as a novel way to modulate the opioid technique, which could open up new therapeutic avenues for opioid-similar Conditions.The positioning is secure. The https:// makes su